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Abstract: Introduction: Recent in vitro studies have shown that chitosan (CS) nanoparticles could enhance the antimicrobial 
activity of several dental materials. However, the biocompatibility of these nanoparticles with normal human cells is 
still controversial. The aim of this study was to evaluate the potential toxicity of various sizes and concentrations of 
CS nanoparticles cultured with normal human dental pulp cells (hDPCs). Methods: Normal hDPCs were derived from 
human dental pulp tissues and cultured with 50–67 nm and 318–350 nm CS nanoparticles in concentrations: 0.2 mg/mL, 
0.5 mg/mL, 1 mg/mL, and 2 mg/mL as study groups and 0 mg/mL as a control. The cell attachment efficiency for each 
group was assessed at 16 h. The proliferation rate and cell viability were evaluated at days 7 and 14. Both attachment 
efficiency and proliferation rate were assessed by measuring the optical density of crystal violet stained cells. The cell 
viability was determined by the activity of the mitochondrial dehydrogenase enzyme. Statistical analysis was performed 
using one-way ANOVA and post hoc Tukey test. Results: All concentrations of 50–67 nm group significantly reduced cell 
attachment efficiency in comparison with the control (P < 0.01) and with 318–350 nm group (P < 0.01). All concentrations 
of both groups, 50–67 nm and 318–350 nm, significantly reduced cell proliferation and cell viability compared to the 
control in dose-dependent and size-associated manners (P < 0.01). Conclusion: Chitosan nanoparticles exhibit a cytotoxic 
effect on normal hDPCs.
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1. Introduction
Chitosan is a cationic polysaccharide derived from another polysaccharide called chitin, which exists naturally within 
the exoskeleton of the crustaceans and shrimps. Chitosan has drawn enormous attention, particularly in the fields of 
medicine and dentistry due to the properties it possesses such as biodegradability, antibacterial action, and bioactivity. 
Examples of chitosan (CS) and CS nanoparticle applications include wound healing[1-4], tissue engineering[5-7], enamel 
caries remineralization[8], an implant coating to improve bone regeneration[9], an antibacterial agent to prevent oral 
diseases, and many more applications[10]. In endodontics, these nanoparticles demonstrated a tremendous ability to kill the 
Enterococcus faecalis bacteria, the bacteria that are known to be broadly involved in most endodontic infections[11]. The 
antibacterial property of zinc oxide eugenol and epoxy resin sealers was enhanced remarkably when they were mixed with 
CS nanoparticles[11,12]. A study also showed that CS nanoparticles significantly reduced the smear layer and the bacterial 
adherence to the root dentin[11,13]. It was also reported that these nanoparticles could be utilized in regenerative endodontics 
as they could provide a temporal controlled release of transforming growth factor-β and dexamethasone to enhance the 
differentiation of the stem cells of apical papilla (SCAP)[14].
In contrast, other studies showed that CS nanoparticles could express a cytotoxic effect on different cell culture. 
For instance, mice embryonic cells and human progenitor liver cells underwent apoptosis after being cultured with 
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various concentrations of CS nanoparticles[15,16]. Such findings raise the necessity to assess the biocompatibility of 
these nanoparticles on the dental pulp before carrying out any clinical trial in dentistry. This study was aimed to 
evaluate the cytotoxicity of various sizes and concentrations of CS nanoparticles cultured with normal human dental 
pulp cells (hDPCs).
2. Materials and Methods
2.1. Cell culture
Dental pulp explants were isolated from freshly extracted pristine third molars provided from 15 to 18-year-old female 
patients under IRB approval. All patients were undergoing a routine third molar extraction at the oral surgery clinic at Boston 
University. The hDPCs were cultured according to the protocol published by Stanislawski et al. with modifications[17]. The 
teeth were split open by a chisel and hammer, and the dental pulp explants were transferred into a 25-cm2 culture flask 
(Thermo Fisher Scientific, USA) containing Basal Medium Eagle’s (BME) culture medium supplemented with 10% fetal 
bovine serum (Atlanta Biologicals), 100 U/mL of penicillin G (Gibco), 100 mg/mL streptomycin (Gibco), and 2.5 mg/mL 
amphotericin-B (Gibco). The dental pulp cells were incubated at humidified atmosphere at 37°C with 5% CO2 (Thermo 
Fisher Scientific, USA) and cultured up to the second passage. The culture medium was replaced every 3 days until the 
cells reached 80% confluence. The cells were then detached from the flask using 0.05% Trypsin-EDTA (Thermo Fisher 
Scientific, USA) and centrifuged (TJ-6 Beckman Centrifuge) for 5 min at 1000 rpm. The cells collected in the pellet were 
counted and utilized for the experiments.
2.2. Nanoparticles preparation
Chitosan nanoparticles were prepared by the ionic gelation method as described by Gan with modifications[18]. For 
50–67 nm nanoparticles, CS (Medium Molecular Weight, Sigma-Aldrich, USA) solution at a concentration of 0.5 mg/mL 
and 0.16 mg/mL sodium-triphosphate solution (sodium-TPP) (Fisher Scientific, USA) were filtered and then stirred 
together for 1 h. 318–350 nm nanoparticles were prepared by stirring a filtered 3 mg/mL CS solution with a filtered 
0.60 mg/mL sodium-TPP solution for 1 h. The size of the particle increases as the CS’s concentration and the CS-TPP 
ratio increases[18]. After stirring, nanoparticles were collected by centrifuging the CS-TPP solutions at 13,000 rpm for 
4 min. The supernatant was discarded and the collected nanoparticles were rinsed extensively by distilled water and then 
suspended in various volumes of BME cell culture medium to create concentrations of 0.2 mg/mL, 0.5 mg/mL, 1 mg/mL, 
and 2 mg/mL. All freshly nanoparticles supplemented culture media were sonicated at 60% amplitude for 5 min for better 
nanoparticles dispersion. Normal hDPCs were then cultured with nanoparticles supplemented media for 7 and 14 days to 
assess the cell attachment, proliferation, and viability.
2.3. Nanoparticles characterization
Mean particles size, size distribution, and the zeta potential of the CS nanoparticles were assessed by the dynamic 
light scattering (90 Plus Particle Size Analyzer, Brookhaven Instrument Corporation, NY, USA) twice, immediately after 
nanoparticles suspension in the culture medium, and once more after 3 days, to monitor the agglomeration of the particles.
2.4. Cell attachment and proliferation rates assessment
Cell attachment was assessed at 16 h. The hDPCs were seeded in 96-well plates (Fisher Scientific) at a density of 
1.5×104 cells per well. The cells were seeded with BME culture medium supplemented with 50–67 nm and 318–350 nm 
CS nanoparticles at concentrations of 0.2 mg/mL, 0.5 mg/mL, 1 mg/mL, and 2 mg/mL as study groups and 0 mg/mL as a 
control. After 16 h, the medium was discarded and the wells were washed 3 times with phosphate-buffered saline (PBS) 
(Thermo Fisher Scientific) to eliminate remnants nanoparticles. Thereafter, the cells were fixed by adding 50 µL of 10% 
neutral buffered formalin (Sigma) for 1 h at room temperature. The fixed cells were then stained by adding 50 µL of 0.2% 
crystal violet stain (Sigma-Aldrich) for another hour. Afterward, all wells were washed 3 times using PBS to remove any 
unbound stains. The density of the stained cells was measured by the microplate reader at wavelength 590 nm.
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The cell proliferation was monitored at day 7 and day 14. The cells were seeded in 96-well plates at a density of 
5×103 cells per well. After an optimal attachment was achieved in each well and before the first round of proliferation, 
i.e., after 16 h, 100 µL of 50–67 nm and 318–350 nm CS-nanoparticles were added at the same concentrations 
mentioned above except for the control. The cell attachment in each well was confirmed microscopically before 
the addition of the nanoparticles. The nanoparticles supplemented culture media were replaced by a fresh one every 
3 days. On each time point, the cells were fixed and stained following the same protocol used in the attachment 
experiment. The optical densities at each point of time were compared to the optical density of 5×103 cells at 16 h as 
a baseline to determine the proliferation rates. The optical density of the crystal violet stain was directly proportional 
to the attached cell numbers.
2.5. Cell viability assessment
Ab112118 Cell Cytotoxicity Assay Kit (Abcam, USA) was used to assess the cell viability. The cells were seeded at 
a density of 5 ×103 cells per well. As in the proliferation experiment, after 16 h, 100 µL of cell culture media containing 
50–67 nm and 318–350 nm CS nanoparticles in concentrations of 0.2 mg/mL, 0.5 mg/mL, 1 mg/mL, and 2 mg/mL were 
added to the cells except for the control. The nanoparticles supplemented culture media were exchanged by a fresh one 
every 3 days. The cell viability was assessed at day 7 and day 14. On the day of the experiment, 20 µL of water-soluble 
tetrazolium salt was added to each well and incubated for 4 h. The mitochondria in viable cells are able to transform the 
tetrazolium into a purple-colored compound called formazan.[19]
The absorbance reading of the produced purple formazan of each group was recorded at wavelengths 570 nm and 
605 nm using the microplate reader. The data then were plugged into the following equation to calculate the percentage 
of viability for each group:
% Cell viability = 100 × (ratio of OD570/OD605-sample – ratio of OD570/OD605-Background)/(ratio of OD570/ 
OD605-control – ratio of OD570/OD605-Background)
2.6. Statistical analysis
All experiments were performed at least in triplicate. One-way ANOVA and post hoc Tukey test were used for the 
statistical analysis utilizing JMP software. The difference was considered significance when P < 0.05.
3. Results
3.1. Chitosan nanoparticles characterizations
The particles size distributions for both groups, 50–67 nm and 318–350 nm, at day 0 and day 3, are illustrated in 
Figure 1a-d. There was no significant agglomeration detected in both groups. The zeta potential was 38.2 mV and 35.6 
mV for groups 50–67 nm and 318–350 nm, respectively.
3.2. Cell attachment and proliferation rates affected by various sizes and concentrations 
of CS nanoparticles
The attachment efficiency of the hDPCs cultured with CS-nanoparticles at 16 h is shown in Figure 2. Cell attachment 
was reduced significantly in 50–67 nm CS-nanoparticles treated groups when compared to the control and to 318–350 nm 
groups (P <0.01).
The influence of various sizes and concentrations of CS-nanoparticles on the proliferation rates of hDPCs is illustrated 
in Figures 3a, b and 4. At day 7, a significant decrease in the number of cells was noticed in groups of 1 mg/mL and 
2 mg/mL of 50–67 nm nanoparticles compared to other groups (P <0.01) (Figure 3a). At day 14, all nanoparticle-treated 
groups showed a significant reduction in the proliferation rates compared to the control (P <0.01) (Figure 3b). At each 
concentration of supplemented nanoparticles, the proliferation rates were significantly lower in the cells treated with 
50–67 nm CS-nanoparticles compared to those treated with 318–350 nm (P < 0.01). Furthermore, both groups, 50–67 nm 
and 318–350 nm, displayed a reduction in the proliferation rates in a dose-dependent manner. Microscopic assessment 
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showed a significant reduction in the number of attached cells in the nanoparticles treated groups as compared to the 
control (Figure 4).
3.3. Cell viability affected by various sizes and concentrations of CS nanoparticles
CS-nanoparticles affected the viability of the hDPCs as shown in Figure 3c and d. The concentrations of 1 mg/mL 
and 2 mg/mL of 50–67 nm CS-nanoparticles reduced cell viability significantly within 7 days as compared to the control 
and 318–350 nm groups (P < 0.01). At day 14, all the nanoparticles treated cells significantly revealed a reduction in the 
viability in dose-dependent and size-associated manners when compared to the control (P < 0.01).
4. Discussion
The inherent antimicrobial property of the CS-nanoparticles has attracted much attention, especially in endodontic 
and preventive dentistry fields. Studies have shown that these nanoparticles can significantly reduce the biofilms of 
Figure 2: Human dental pulp cells attachment efficiency in culture media supplemented with various sizes and concentrations of 
chitosan nanoparticles. The data are presented as means of six experiments with error bars indicating standard deviations (*P < 0.01).
Figure 1: Characterization of chitosan nanoparticles as obtained from dynamic light scattering. (A) The size distribution of the smaller 
particles group, immediately after ultrasonic cavitation in culture medium, ranging from 25 nm to 116 nm with a median of 54 nm and a mean 
of 50 nm. (B) The size distribution of the smaller particles group, after 3 days from ultrasonic cavitation, ranging from 26 nm to 133 nm with a 
median of 60 nm and a mean of 67 nm. (C) The size distribution of the larger particles group, immediately after ultrasonic cavitation in culture 
medium, ranging from 107 nm to 685 nm with a median of 271 nm and a mean of 318 nm. (D) The size distribution of the larger particles 
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Figure 4: Micrographs show the influence of different chitosan nanoparticles concentrations on the proliferation of human dental 
pulp cells stained with crystal violet. The top two micrographs represent the proliferation of the control group from 16 h until day 14. 
The middle and bottom micrographs illustrate the proliferation of the cells in the presences of 0.2 mg/mL and 2 mg/mL, respectively.
Figure 3: (A and B) The influence of various sizes and concentrations of chitosan nanoparticles on the human dental pulp cells 
proliferation at day 7 and day 14, respectively. The data are presented in folds which were calculated by dividing the cell number on 
the day of the experiment by the cell number at 16 h, 5×103 cells per well. The viability of human dental pulp cells exposed to various 
sizes and concentrations of chitosan nanoparticles for 7 days and 14 days is shown in C and D, respectively. The data are presented 
as means of six separate experiments with error bars indicating standard deviations. Groups that carry, *, **, or different letters differ 





6 | Rami Alhomrany et al. 
E. faecalis and Streptococcus mutans, bacteria which are associated with the periapical infections and dental carries, 
respectively[11,20]. Another recent study demonstrated that photoactivated Rose Bengal CS nanoparticles can significantly 
disinfect LPS-contaminated root canals[21]. This antimicrobial property was exploited by researchers to improve the 
antibacterial activity of several dental materials such as zinc oxide-eugenol sealer, epoxy resin sealer, calcium hydroxide 
medicament, and composite restoration[11,12,22,23]. Moreover, it has been reported that the modified CS nanoparticles could 
serve as a promising indirect dental pulp capping material as it plays a role in the remineralization of a demineralized 
dentin in a deep caries tooth model[24]. In parallel with the antibacterial studies, others have raised concerns about the 
biocompatibility of these nanoparticles on normal cell cultures. It is imperative to evaluate the potential toxicity of these 
nanoparticles on a cell culture that is more relevant to the dental clinical situation. Although a numerous number of 
studies had discussed the properties of CS-nanoparticles as a promising polymer in the field of dentistry, there is a limited 
knowledge regarding its biocompatibility with normal hDPCs. To the best of the authors’ knowledge, this is the first 
report that evaluated the potential toxicity of various sizes and concentrations of CS-nanoparticles on dental pulp cells 
derived from healthy human. Due to the possible interaction between the nanoparticles and dental pulp in some clinical 
application, it is becoming a pressing issue to determine the most appropriate concentration and size of CS nanoparticles 
to be utilized without causing any toxicity to the dental pulp.
The chosen concentrations in the present study were either similar or lower than the concentrations tested on the previous 
antimicrobial studies. Antimicrobial studies indicated that CS nanoparticles in concentrations of 2 mg/mL, 5 mg/mL, and 
10 mg/mL could kill E. faecalis bacteria effectively[25]. Another report was published by Arancibia et al. presented that, 
only at a concentration of 5 mg/mL, CS nanoparticles were efficacious in suppressing the growth of Aggregatibacter 
actinomycetemcomitans and Porphyromonas gingivalis, the bacteria which are associated with periodontal diseases[26]. 
Likewise, the growth of the cariogenic streptococci was significantly downregulated after exposure to CS nanoparticles in 
concentrations of 1.25 mg/mL, 2 mg/mL, and 5 mg/mL[27]. In addition, the anticandidal property of CS nanoparticles was 
reported by Ing et al. In that study, it was shown that the minimum inhibitory concentration of CS nanoparticles to reduce 
the growth of 90% of Candida albicans was 0.2 mg/mL[28]. The findings of the present study suggest that CS nanoparticles 
in concentrations of 0.2 mg/mL, 0.5 mg/mL, 1 mg/mL, and 2 mg/mL induced a cytotoxic effect on normal hDPCs in 
dose-dependent and size-associated manners.
The cytotoxicity of CS nanoparticles was previously observed on animal models. In Park et al. study, 100 nm CS 
nanoparticles showed an inhibitory antiproliferative effect on embryonic mice cells in a dose-dependent manner. In that 
study, there was an upregulation in apoptotic proteins such as Bad and Bax, as the concentration of the CS-nanoparticles 
increased from 0.01 mg/mL up to 0.2 mg/mL[16]. Another study, conducted on a zebrafish model exposed to 250 nm 
CS-nanoparticles, showed variable mortality rates with different concentrations. Nearly 100% mortality rate was achieved 
with concentration of 0.05 mg/mL while only <20% mortality rate was noticed with a concentration of 0.005 mg/mL[29]. 
Furthermore, another paper reported by Almalik et al. showed the significant release of lactate dehydrogenase enzyme, 
production of reactive oxygen species, and reduction in cell viability, in Chinese hamster ovary cell culture exposed to 
222 nm CS nanoparticles at a dose of 2.5 mg/mL for 24 h[30].
Another critical aspect of the present study is the comparison between the effects of different particles sizes. To 
accurately assess the nanoeffect of CS, it was crucial to control the particle size in the culture medium. In a complex 
biological solution, suspended nanoparticles are normally confronted with several forces. Whenever the exerted van 
der Waals forces on nanoparticles exceed the repulsive electrostatic force, the nanoparticles tend to agglomerate[31]. 
Furthermore, nanoparticles surface charge[32], concentration[33], size[34], structure[35], chemical composition[36], and 
organic constituents in culture medium[31] appeared to be factors contributed to the formation of large agglomerates. 
Formation of micrometer large agglomerates in culture media creates a challenging issue as this could complicate the 
researcher’s ability to deduce the nanoparticles interaction with living cells. Herein, the ultrasonic cavitation effectively 
disintegrated the large agglomerates in the culture medium and kept the nanoparticles stable for 3 days. Because the 
nanoparticles remained stable for 3 days, the nanoparticle-supplemented medium was replaced by a fresh one every 
3 days until the end of the experiment. In the present study, it was observed that the toxicity induced by 50–67 nm particles 
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was significantly higher as compared to 318–350 nm particles at each concentration. There was limited knowledge 
regarding the nanotoxicity induced by different sizes of CS nanoparticles; however, this size-dependent nanotoxicity 
was observed with other types of nanoparticles, such as silica and hydroxyapatite nanoparticles, cultured with different 
cell populations. The findings reported by Xu et al. showed that 20 nm silica nanoparticles induced higher cytotoxicity 
on human lung fibroblasts in comparison with 80 nm at each concentration used in that study[37]. Furthermore, an 
analogous effect reported with hydroxyapatite nanoparticles cultured with human hepatoma HepG2 cells. In that study, 
human hepatoma cells underwent size-dependent cytotoxicity and apoptosis[38]. This size-associated nanotoxicity is 
probably due to the fact that smaller nanoparticles are more susceptible to cellular uptake when compared with larger 
nanoparticles.
Differently, the viability of SCAP was not affected when the cells were cultured with 0.3 mg/mL CS-nanoparticles 
for 24 h[39]. Another study suggested that 0.6 mg/mL CS nanoparticles displayed no significant alteration on the viability 
of the human gingival fibroblasts after 72 h culture time[40]. In that study, interestingly, concentrations of 0.1 mg/mL and 
0.3 mg/mL exhibited a proliferative effect on the human gingival fibroblasts within 72 h[40]. These opposite findings might 
be primarily referred to the short exposure time. In the present study, it was observed that low concentration such as 
0.2 mg/mL required 2 weeks to induce a cytotoxic effect on the hDPCs, which underlines the importance of a prolonged 
culture time in cytotoxicity assessment.
It is well known that the CS-nanoparticles obtain a positive charge due to the presence of active amino groups within 
their composition[41]. The potential toxicity induced by these nanoparticles might be due to an electrostatic interaction 
between these cationic nanoparticles and the negatively charged cellular membrane[42]. The small size of these nanoparticles 
probably allowed them to penetrate the cellular membrane and, consequently, led to cellular death. In a study where the 
liver cells were exposed to CS nanoparticles, transmission electron microscopy images revealed that these nanoparticles 
can internalize the cells and deteriorate the nuclear membrane readily[15]. However, further investigations are still needed 
to clearly understand the molecular pathways behind the toxicity induced by CS nanoparticles.
5. Conclusion
Chitosan nanoparticles at sizes 50–67 nm and 318–350 nm in concentrations of 0.2 mg/mL, 0.5 mg/mL, 1 mg/mL, 
and 2 mg/mL possess a cytotoxic effect on the normal hDPCs in dose-dependent and size-associated manners.
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